Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
ClinicalTrials.gov study NCT06125652. IPD Sharing: NO. Countries: 1. Publications: 0.
Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01373515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00006213. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00295841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT06180863. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients
ClinicalTrials.gov study NCT02602587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02181660. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05100303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05722171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06802718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02905994. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00762632. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02892318. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00131989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00093418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05190471. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01076569. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Validation Study of a New Cytokine-based Dynamic Stratification Based on FLt3 Ligand Plasma Concentration Kinetic Profile and IL-6 Concentration During Induction of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04641910. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00454480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00101296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.